UPC: Universe Pharmaceuticals Inc. Market Capitalization to Book Value Ratio

Strategic alliances with distributors of Chinese pharmaceuticals are scaling sales for Universe Pharmaceuticals (UPC), as confirmed by the company's P/BV chart. The robotization of warehouse logistics is optimizing staffing and accelerating order fulfillment. However, intense local competition in the regions limits expansion, despite loyalty among elderly clients. The current value of 0.02 reflects the latest metric for the price-to-book value ratio.

Universe Pharmaceuticals (UPC) - Market Capitalization to Book Value Ratio from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company Universe Pharmaceuticals Inc. (UPC)

- market value and analyst target forecast:

Price Chart Universe Pharmaceuticals|UPC - Forecast Levels Chart

- market capitalization information:

Market Capitalization Universe Pharmacy|UPC - Value Adjusted for Debt and Cash

- balance sheet net asset value indicators:

Book Value per Share Universe Pharmaceuticals|UPC - Book Capitalization|Market Value to Book Value Ratio universe-pharmacy.com|UPC - Aggregate Asset Value

- business debt structure and liquidity details:

Debt to Equity Universe Pharmaceuticals|UPC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Universe Pharmacy|UPC - Company Aggregate Debts|Debts to Book Capitalization Universe Pharmacy|UPC - Company Long-Term Liabilities|Company Current Liabilities Universe Pharmaceuticals|Quick Liquidity Indicator universe-pharmacy.com

- earnings and valuation multiples indicators:

UPC - Net Profit

Initial company analysis:Universe Pharmaceuticals - UPC

Manufactured product of Universe Pharmaceuticals Inc.

This ratio compares the market value of the business with its equity to determine the degree of asset overvaluation. For Universe Pharmaceuticals (UPC), steady demand for traditional medicine drugs minimizes the volatility of this metric. Analyzing the ratio of the company's market value to its book assets allows for the identification of deviations from the fair price. The metric's trend serves as a signal for portfolio rebalancing. The business's high macro-resilience provides a reliable foundation for capitalization.

Main competitors

cvshealth.com (CVS) - Market Value to Book Value Ratio|Market Capitalization to Net Assets MCK (mckesson.com)|COR (Cencora) - Market Capitalization to Book Value Ratio|CAH: Market Value to Book Value|Market Capitalization to Book Value Ratio HSIC|Market Capitalization to Book Value Ratio Prestige Corp (PBH)|Market Value to Book Value Ratio Wellgistics Health WGRX|Market Value to Book Value YI|RDGT - Market Value to Book Value Ratio|Biodexa Pharmaceuticals (BDRX) - Market Cap to Net Assets Ratio|HKPD: Market Capitalization to Book Value Ratio|BIMI Holdings Inc (BIMI) - Market Capitalization to Book Value Ratio|CJJD (China Jo-Jo Drugstores Inc.) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Walgreens (WBA)